Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer.
Bicarbonates
Surface Plasmon Resonance
Filiberti, Allen
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance.
See All 11 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance.
van de Donk NWCJ, Usmani SZ. CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance. Front Immunol. 2018; 9:2134.
View in:
PubMed
subject areas
ADP-ribosyl Cyclase 1
Antibodies, Monoclonal
Antibody-Dependent Cell Cytotoxicity
Antineoplastic Agents, Immunological
Apoptosis
B-Lymphocytes, Regulatory
Drug Resistance, Neoplasm
Gene Expression Regulation, Neoplastic
Humans
Immunoglobulin Fc Fragments
Membrane Glycoproteins
Multiple Myeloma
Myeloid-Derived Suppressor Cells
Phagocytosis
Randomized Controlled Trials as Topic
T-Lymphocytes, Regulatory
Treatment Outcome
Tumor Microenvironment
authors with profiles
Saad Usmani MD